| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA652529 | F | Cytotoxicity was determined by inhibition against the Burkitt lymphoma CA46 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA652530 | F | Inhibits the growth of the human Burkitt lymphoma CA46 cell | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 3. | ALA908003 | F | Cytotoxicity against human CA46 cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 4. | ALA904239 | F | Inhibition of c-myc expression in CA46 cells at 10 uM | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 5. | ALA905339 | F | Growth inhibition of CA46 cells | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 6. | ALA2040536 | F | Antiproliferative activity against human CA46 cells | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 7. | ALA2040537 | F | Cell cycle arrest in human CA46 cells assessed as mitotic cells at 10 times IC50 (Rvb = 2 to 4%) | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 8. | ALA2040350 | F | Growth inhibition of c-myc NHE III1-deficient human CA46 cell line at 2.5 to 10 uM after 4 days by cell counting | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA2040352 | F | Down-regulation of c-myc gene expression in human CA46 cells at 0.5 to 5 uM after 4 days by RT-PCR analysis | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 10. | ALA937437 | F | Cytotoxicity against human CA46 cells assessed as reduction in cellular ATP level after 48 hrs | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 11. | ALA2034788 | F | Decrease in c-myc expression in promoter element P1 and P2-deficient human CA46 cells by RT-PCR analysis | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA2155843 | F | Induction of senescence in human CA46 cells assessed as flat cells at 0.05 to 0.1 uM after 16 days by beta galactosidase assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA2155844 | F | Induction of senescence in human CA46 cells assessed as gaint cells at 0.05 to 0.1 uM after 16 days by beta galactosidase assay assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA2155854 | F | Antiproliferative activity against cmyc NHE III1 element-deficient human CA46 cells assessed as cell viability after 20 days | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA997469 | F | Antiproliferative activity against human CA46 cells after 24 hrs | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 16. | ALA957769 | F | Cell cycle arrest in human CA46 cells assessed as accumulation at G2/M phase at 0.2 uM after 24 hrs using propidium iodide labeling by flow cytometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA957770 | F | Cell cycle arrest in human CA46 cells assessed as accumulation at G2/M phase at 1.0 uM after 24 hrs using propidium iodide labeling by flow cytometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA957772 | F | Effect on microtubule cytoskeleton in human CA46 cells | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 19. | ALA957773 | U | Ratio of IC50 for rat kangaroo Ptk2 cells to IC50 for human CA46 cells | 1 | cell-based format | Scientific Literature | |||
| 20. | ALA996751 | F | Induction of telomere shortening in human CA46 cells assessed as telomere length at 1.8 uM by telomeric restriction fragment assay | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!